All locations

See a listing of all our Children’s Hospital Colorado locations including inpatient, outpatient, therapy, surgery facilities and more.

Locations near you

See all locations

Myron Levin, MD

Provider's Specialties

Internal Medicine

Provider's location(s)

Anschutz Medical Campus, Aurora

View map

Patient ratings

Patient ratings and reviews are not available

Why?

Pediatric Infectious Disease Program

(303)724-2451

Insurance plans accepted

We participate with most major health insurance plans and national transplant networks.

View the full list

Prepare for your visit

We want to make sure you know what to expect before you arrive.

See the checklist

Get to know Myron Levin, MD

Departments and Programs

Infectious Disease

Conditions Treated

Viral Infections
Sexually Transmitted Diseases
AIDS
AIDS / HIV Disease

Languages spoken

English

Experience and background

I am interested in Clinical Virology, Antiviral Therapy and Herpes Virus Infections.

Undergraduate 1960

Harvard University (MA)

Medical Education 1964

Harvard Medical School

Internship 1965

Albert Einstein College of Medicine (Jacobi) Program

Residency 1966

Albert Einstein College of Medicine (Jacobi) Program

Fellowship 1971

Beth Israel Deaconess Medical Center Program

For Patients:
Dr. Levin is studying the immune response to herpes virus infections and methods of treating and preventing such infections, including antiviral therapy and active immunization. He does basic research on the nature of latency of herpes viruses in human neurons. A vaccine to prevent shingles in elderly individuals has been developed and licensed through his clinical research, and further investigations of this vaccine are in progress.

For Referring Providers:
Dr. Levin is studying the immune response to herpes virus infections and methods of treating and preventing such infections, including antiviral therapy and active immunization. He does basic research on the nature of latency of herpes viruses in human neurons. A vaccine to prevent shingles in elderly individuals has been developed and licensed through his clinical research, and further investigations of this vaccine are in progress.